These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19966801)

  • 61. The selective packaging and annealing of primer tRNALys3 in HIV-1.
    Kleiman L; Halwani R; Javanbakht H
    Curr HIV Res; 2004 Apr; 2(2):163-75. PubMed ID: 15078180
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Murine leukemia virus with a primer-binding site complementary to tRNALys,3 adapts to select new tRNAs for replication following extended in vitro culture.
    Palmer MT; McPherson S; Morrow CD
    Virology; 2005 Mar; 333(2):337-48. PubMed ID: 15721366
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Destabilization of tRNA3(Lys) from the primer-binding site of HIV-1 genome by anti-A loop polyamide nucleotide analog.
    Kaushik N; Talele TT; Monel R; Palumbo P; Pandey VN
    Nucleic Acids Res; 2001 Dec; 29(24):5099-106. PubMed ID: 11812842
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Probing the importance of tRNA anticodon: human immunodeficiency virus type 1 (HIV-1) RNA genome complementarity with an HIV-1 that selects tRNA(Glu) for replication.
    Dupuy LC; Kelly NJ; Elgavish TE; Harvey SC; Morrow CD
    J Virol; 2003 Aug; 77(16):8756-64. PubMed ID: 12885895
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of human immunodeficiency virus type 1 reverse transcriptase primer tRNA binding by fluorescence spectroscopy: specificity and comparison to primer/template binding.
    Thrall SH; Reinstein J; Wöhrl BM; Goody RS
    Biochemistry; 1996 Apr; 35(14):4609-18. PubMed ID: 8605212
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNA(3Lys).
    Wakefield JK; Wolf AG; Morrow CD
    J Virol; 1995 Oct; 69(10):6021-9. PubMed ID: 7545240
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Structural requirements for the binding of tRNA Lys3 to reverse transcriptase of the human immunodeficiency virus type 1.
    Oude Essink BB; Das AT; Berkhout B
    J Biol Chem; 1995 Oct; 270(40):23867-74. PubMed ID: 7559565
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Defective replication in human immunodeficiency virus type 1 when non-primers are used for reverse transcription.
    Wei M; Cen S; Niu M; Guo F; Kleiman L
    J Virol; 2005 Jul; 79(14):9081-7. PubMed ID: 15994802
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficient initiation of HIV-1 reverse transcription in vitro. Requirement for RNA sequences downstream of the primer binding site abrogated by nucleocapsid protein-dependent primer-template interactions.
    Iwatani Y; Rosen AE; Guo J; Musier-Forsyth K; Levin JG
    J Biol Chem; 2003 Apr; 278(16):14185-95. PubMed ID: 12560327
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Roles of Gag and NCp7 in facilitating tRNA(Lys)(3) Annealing to viral RNA in human immunodeficiency virus type 1.
    Guo F; Saadatmand J; Niu M; Kleiman L
    J Virol; 2009 Aug; 83(16):8099-107. PubMed ID: 19494012
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In virio SHAPE analysis of tRNA(Lys3) annealing to HIV-1 genomic RNA in wild type and protease-deficient virus.
    Seif E; Niu M; Kleiman L
    Retrovirology; 2015 May; 12():40. PubMed ID: 25981241
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Genetic analysis of the U5-PBS of a novel HIV-1 reveals multiple interactions between the tRNA and RNA genome required for initiation of reverse transcription.
    Zhang Z; Kang SM; Li Y; Morrow CD
    RNA; 1998 Apr; 4(4):394-406. PubMed ID: 9630246
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of altering the tRNA(Lys)(3) concentration in human immunodeficiency virus type 1 upon its annealing to viral RNA, GagPol incorporation, and viral infectivity.
    Gabor J; Cen S; Javanbakht H; Niu M; Kleiman L
    J Virol; 2002 Sep; 76(18):9096-102. PubMed ID: 12186893
    [TBL] [Abstract][Full Text] [Related]  

  • 74. MD simulations of HIV-1 RT primer-template complex: effect of modified nucleosides and antisense PNA oligomer.
    Uppuladinne MV; Sonavane UB; Joshi RR
    J Biomol Struct Dyn; 2013; 31(6):539-60. PubMed ID: 22888964
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The fidelity of reverse transcription differs in reactions primed with RNA versus DNA primers.
    Oude Essink BB; Berkhout B
    J Biomed Sci; 1999; 6(2):121-32. PubMed ID: 10087443
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synthetic tRNALys,3 as the replication primer for the HIV-1HXB2 and HIV-1Mal genomes.
    Miller JT; Khvorova A; Scaringe SA; Le Grice SF
    Nucleic Acids Res; 2004; 32(15):4687-95. PubMed ID: 15342789
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Profiling non-lysyl tRNAs in HIV-1.
    Pavon-Eternod M; Wei M; Pan T; Kleiman L
    RNA; 2010 Feb; 16(2):267-73. PubMed ID: 20007329
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Polyamide nucleic acid targeted to the primer binding site of the HIV-1 RNA genome blocks in vitro HIV-1 reverse transcription.
    Lee R; Kaushik N; Modak MJ; Vinayak R; Pandey VN
    Biochemistry; 1998 Jan; 37(3):900-10. PubMed ID: 9454580
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Inability of human immunodeficiency virus type 1 produced in murine cells to selectively incorporate primer formula.
    Wei M; Yang Y; Niu M; Desfosse L; Kennedy R; Musier-Forsyth K; Kleiman L
    J Virol; 2008 Dec; 82(24):12049-59. PubMed ID: 18842718
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Heteronuclear NMR studies of the interaction of tRNA(Lys)3 with HIV-1 nucleocapsid protein.
    Tisné C; Roques BP; Dardel F
    J Mol Biol; 2001 Feb; 306(3):443-54. PubMed ID: 11178904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.